Secondary Adrenal Insufficiency: Glucocorticoid Replacement Regimen
For secondary adrenal insufficiency, initiate hydrocortisone 15-25 mg daily divided into 2-3 doses (typically 10 mg morning, 5 mg midday, and optionally 2.5-5 mg afternoon), with NO mineralocorticoid replacement needed, and implement stress-dose protocols that double the daily dose for minor illness and require parenteral administration for major stress. 1, 2
Daily Maintenance Therapy
Glucocorticoid Replacement
- Hydrocortisone is the preferred agent at 15-25 mg daily in adults, divided into 2-3 doses to mimic physiological cortisol rhythm 1, 2
- Typical dosing schedule: 10 mg upon awakening, 5 mg at midday, optional 2.5-5 mg in late afternoon
- Alternative: Prednisone 3-5 mg daily if hydrocortisone unavailable 2
- Avoid long-acting synthetic glucocorticoids (dexamethasone, high-dose prednisolone) as primary therapy due to increased adverse metabolic effects 1
Mineralocorticoid Replacement
- NOT required in secondary adrenal insufficiency because the renin-angiotensin-aldosterone system remains intact (aldosterone production is preserved) 1, 2
- This is a critical distinction from primary adrenal insufficiency
Stress-Dose Protocols
Minor Stress (Fever, Infection, Emotional Stress, Minor Surgery with Local Anesthesia)
- Double the daily glucocorticoid dose until stress resolves 3
- Example: If on hydrocortisone 20 mg daily, increase to 40 mg daily (20 mg morning, 10 mg midday, 10 mg evening)
- Patients already taking prednisone ≥10 mg daily typically do not need additional coverage 3
Moderate to Major Stress (Hospitalization, Major Trauma, Surgery with General Anesthesia, Labor/Cesarean Section)
- Parenteral glucocorticoids are mandatory until stress resolves 3
- Hydrocortisone 40 mg daily parenterally (or equivalent doses of methylprednisolone/dexamethasone) 3
- For surgery: Continue parenteral administration throughout perioperative period with long recovery times
Prolonged Vomiting/Diarrhea Without Hemodynamic Instability
- Consider parenteral glucocorticoids to prevent adrenal crisis due to impaired oral absorption 3
- This is a common pitfall—gastrointestinal illness significantly increases adrenal crisis risk
Suspected Adrenal Crisis (Hemodynamic Instability, Severe Vomiting)
- Immediate treatment takes precedence over diagnostic confirmation 3
- Administer parenteral hydrocortisone 100 mg immediately with aggressive fluid resuscitation 2
- Continue hydrocortisone infusion or repeated parenteral doses until stabilized
Monitoring and Patient Education
Clinical Monitoring
- Assess for signs of under-replacement: persistent fatigue, weight loss, hypotension, hypoglycemia
- Assess for signs of over-replacement: weight gain, hyperglycemia, hypertension, cushingoid features
- Glucocorticoid replacement therapy increases risk of worsening glucose metabolism, particularly in patients with pre-existing impaired glucose tolerance or diabetes (OR: 2.3) 4
Critical Patient Education Points
- All patients must carry emergency injectable hydrocortisone (100 mg intramuscular) and know how to self-administer 2
- Provide written sick-day rules for dose adjustment
- Medical alert identification (bracelet/card) is essential
- Educate on recognizing adrenal crisis symptoms: severe weakness, confusion, abdominal pain, hypotension
Important Clinical Pitfalls
Gastrointestinal illness is particularly dangerous: Studies show only 55% of patients appropriately increase glucocorticoid doses during GI infections, despite high adrenal crisis risk 5. Emphasize the need for parenteral administration when oral absorption is compromised.
Avoid excessive dose increases for minor symptoms: Some patients inappropriately double doses for low-severity symptoms 5. Provide clear symptom severity thresholds for dose adjustment.
Rapid correction after prolonged deficiency carries risks: When treating severe, prolonged adrenal insufficiency with significant hyponatremia, hydrocortisone can cause rapid sodium correction leading to osmotic demyelination syndrome 6. Monitor sodium closely and correct slowly (≤8-10 mEq/L per 24 hours).
The 2024 European Society of Endocrinology/Endocrine Society joint guidelines 3 provide the most current evidence-based framework, emphasizing that stress-dose regimens must be individualized based on clinical judgment, but the fundamental principle remains: prevention of adrenal crisis through adequate glucocorticoid coverage during physiological stress is paramount for reducing mortality risk.